[Intensity-modulated radiotherapy in cervical cancer: towards a new standard?].
Intensity modulated radiation therapy has demonstrated its ability to prevent xerostomia in the treatment of head and neck cancers, as well as post-radiation related proctitis in prostate cancer. In the management of cervical carcinomas, many published dosimetric studies have shown its ability to limit the irradiation of organs at risk. However, clinical data remain limited to comparisons of cohorts, mostly retrospective, but promising. This review aims to update the current state of knowledge.
Département de radiothérapie, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: renaud.mazeron@gustaveroussy.fr.
R
R
Mazeron
Département de radiothérapie, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
I
I
Dumas
Département de radiothérapie, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
C
C
El Khouri
Département de radiothérapie, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
A
A
Lévy
Département de radiothérapie, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
M
M
Attar
Département de radiothérapie, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
C
C
Haie-Meder
D001853:Bone Marrow; D005260:Female; D006801:Humans; D058958:Organs at Risk; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy*
Cancer du col de l’utérus; Cancer of the cervix; Dosimetry; Dosimétrie; Intensity modulated radiation therapy; Morbidity; Morbidité; Radiothérapie conformationelle avec modulation d’intensité